Developers: | Radialis Medical |
Date of the premiere of the system: | July 2022 |
Branches: | Pharmaceuticals, Medicine, Healthcare |
2022: Portable PET device for scanning certain organs introduced
In early July 2022, Radialis Medical introduced the Radialis PET Imager portable positron emission tomography imaging machine. The system entered the market with the ability to adapt to the patient, and not vice versa, the manufacturer claims.
Positron emission tomography (PET) is a modern method of medical imaging, the very essence of PET is that before the study, a pharmaceutical drug containing a radioactive component - a radiopharmaceutical (it can be chemically modified glucose) is introduced into the body. In the body, the drug breaks down with the release of positrons. The latter begin to interact with electrons of organs and tissues, as a result, special electromagnetic radiation occurs, recorded by special sensors. According to its characteristics, it is concluded about the state of the observed structures at the molecular and cellular level.
As the system from Radialis Medical narrows its field of view, covering only a specific organ or body site, it can get better images than full-body PET scans, the Canadian equipment manufacturer said. It is also particularly sensitive to introduced radioactive substances. The developers claim that her device can collect 10 times more imaging data than other high-tech PET scanners, which are known for July 2022.
The system is equipped with two planar detectors, which, if necessary, can be rotated, moved above or below and extended by different widths. These adjustments allow the scanner to be used on patients who sit, stand or lie, as well as for various types of scans from mammography to neurology and cardiology. Once a given area is in the scanner's field of view, the device detects any positron-emitting radio transmitter to narrow the research area. The system then produces high-resolution images of the area, allowing you to select objects up to 1.3 mm in size.
PET shows not only the structure, structure of the studied area, but also its function. Glucose from the administered radiopharmaceutical is included in the metabolism, and with the help of the apparatus it can be recorded how it behaves in a particular tissue or organ. It is known that the cells of malignant tumors grow rapidly, and this happens for a reason: a lot of energy is needed for rapid growth. Introduced glucose is more intensively consumed by the cells of the tumor tissue, which makes it possible to see them on tomograms, 'said Radialis Medical CEO Michael Waterston. |
The scanner from Radialis Medical has entered the market specifically for imaging and measuring the radioactive substances administered to determine the various metabolic and physiological functions of the body. In particular, the developers said they hope that their organ-specific approach to PET scanning will become the main method for early detection of hard-to-detect diseases.[1]